One of the actual controllers of YONGAN PHARMACEUTICAL, Huanggang Yongan, intends to reduce its holdings by no more than 0.91% of the shares
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, YONGAN PHARMACEUTICAL announced that its controlling shareholder and actual controller, the concerted actor Huanggang Yongan Pharmaceutical Co., Ltd. (hereinafter referred to as "Huanggang Yongan"), plans to reduce its holdings of the company's shares by no more than 2.6323 million shares (accounting for 0.91% of the total share capital after excluding shares in the company's repurchase special account) through centralized bidding or block trading within three months after fifteen trading days from the date of this announcement
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments